Results Snapshot
Figures in Million
Consolidate Annual Results
Jan'24
Jan'23
Jan'22
Jan'21
Dec'19
Net Sales
19.14
15.49
9.64
3.85
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
19.14
15.49
9.64
3.85
0.00
Raw Material Cost
1.18
1.07
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
3.41
2.95
4.27
1.27
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.31
0.41
0.18
0.04
0.00
Selling and Distribution Expenses
23.29
19.48
16.03
4.96
0.10
Other Expenses
-0.47
-0.31
-0.44
-0.13
0.00
Total Expenditure (Excl Depreciation)
24.47
20.79
16.03
4.96
0.10
Operating Profit (PBDIT) excl Other Income
-5.300000000000001
-5.300000000000001
-6.4
-1.1
-0.1
Other Income
0.31
0.22
0.34
-0.14
0.00
Operating Profit (PBDIT)
-3.83
-4.01
-6.06
-1.25
-0.10
Interest
1.31
0.41
0.18
0.04
0.00
Exceptional Items
-1.12
-1.50
-1.48
-8.86
-0.03
Gross Profit (PBDT)
17.97
14.42
0.00
0.00
0.00
Depreciation
1.18
1.07
0.52
0.14
0.00
Profit Before Tax
-7.44
-6.99
-8.23
-10.29
-0.13
Tax
-0.81
-0.09
-0.22
-0.38
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-6.64
-6.90
-7.81
-9.90
-0.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
-6.64
-6.90
-7.81
-9.90
-0.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.21
-0.01
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-6.64
-6.90
-8.02
-9.91
-0.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
Reserves
-5.95
-1.87
4.08
8.53
0.39
Earnings per share (EPS)
-0.08
-0.08
-0.1
-0.19
-0.13
Diluted Earnings per share
-0.08
-0.08
-0.1
-0.19
-0.13
Operating Profit Margin (Excl OI)
-27.79%
-34.23%
-71.71%
-32.58%
0.0%
Gross Profit Margin
-32.71%
-38.21%
-80.06%
-263.47%
0.0%
PAT Margin
-34.66%
-44.57%
-81.0%
-257.05%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Jan 2024 is 23.23% vs 61.46% in Jan 2023
Consolidate Net Profit
YoY Growth in year ended Jan 2024 is 4.35% vs 13.75% in Jan 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Jan 2024 is 2.38% vs 34.38% in Jan 2023
Interest
YoY Growth in year ended Jan 2024 is 225.00% vs 100.00% in Jan 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Jan 2024 has improved from Jan 2023
Compare Annual Results Of Jack Nathan Medical Corp. With
Figures in Million
Consolidate Annual Results
Change(CAD)
Change(%)
Net Sales
19.14
0.00
19.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
19.14
0.00
19.14
Raw Material Cost
1.18
0.07
1.11
1,585.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
3.41
0.49
2.92
595.92%
Power Cost
0
0
0.00
Manufacturing Expenses
1.31
0.01
1.30
13,000.00%
Selling and Distribution Expenses
23.29
2.11
21.18
1,003.79%
Other Expenses
-0.47
-0.05
-0.42
-840.00%
Total Expenditure (Excl Depreciation)
24.47
2.20
22.27
1,012.27%
Operating Profit (PBDIT) excl Other Income
-5.32
-2.20
-3.12
-141.82%
Other Income
0.31
-0.01
0.32
3,200.00%
Operating Profit (PBDIT)
-3.83
-2.14
-1.69
-78.97%
Interest
1.31
0.01
1.30
13,000.00%
Exceptional Items
-1.12
-0.04
-1.08
-2,700.00%
Gross Profit (PBDT)
17.97
-0.07
18.04
25,771.43%
Depreciation
1.18
0.07
1.11
1,585.71%
Profit Before Tax
-7.44
-2.26
-5.18
-229.20%
Tax
-0.81
0.00
-0.81
Provisions and contingencies
0
0
0.00
Profit After Tax
-6.64
-2.26
-4.38
-193.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-6.64
-2.26
-4.38
-193.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-6.64
-2.26
-4.38
-193.81%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-5.95
-1.86
-4.09
-219.89%
Earnings per share (EPS)
-0.08
-0.04
-0.04
-100.00%
Diluted Earnings per share
-0.08
-0.04
-0.04
-100.00%
Operating Profit Margin (Excl OI)
-27.79%
0.00%
0.00
-27.79%
Gross Profit Margin
-32.71%
0.00%
0.00
-32.71%
PAT Margin
-34.66%
0.00%
0.00
-34.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1.91 Million
in Jan 2024Figures in Million
YoY Growth in year ended Jan 2024 is 23.23% vs 61.46% in Jan 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -0.66 Million
in Jan 2024Figures in Million
YoY Growth in year ended Jan 2024 is 4.35% vs 13.75% in Jan 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.41 Million
in Jan 2024Figures in Million
YoY Growth in year ended Jan 2024 is 2.38% vs 34.38% in Jan 2023
Annual - Interest
Interest 0.13 Million
in Jan 2024Figures in Million
YoY Growth in year ended Jan 2024 is 225.00% vs 100.00% in Jan 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -27.79%
in Jan 2024Figures in %
YoY Growth in year ended Jan 2024 has improved from Jan 2023






